Fralex Therapeutics Inc.
|
|||
| Mailing Address: | 5959 Trans-Canada Highway Montreal, Quebec H4T 1A1 |
Head Office Address: | 5959 Trans-Canada Highway Montreal, Quebec H4T 1A1 |
| Contact Name: | Krishan Shah | Principal Regulator: | Ontario |
| Business e-mail address: | kshah@baylismedical.com | Short Form Prospectus Issuer: | No |
| Telephone Number: | 905 602-4875 | Reporting Jurisdictions: | British Columbia, Alberta, Saskatchewan, Manitoba, Ontario, Quebec, New Brunswick, Nova Scotia, Prince Edward Island, Newfoundland |
| Fax Number: | 905 602-5671 | Stock Exchange: | N/A |
| Date of Formation: | Sep 16 1998 | Stock Symbol: | FXI |
| Jurisdiction Where Formed: | Ontario | Auditor: | PriceWaterhouseCoopers LLP |
| Industry Classification: | consumer products - biotechnology/pharmaceuticals | General Partner: | |
| CUSIP Number: | Transfer Agent: | Computershare Trust Company of Canada | |
| Financial Year-End: | Dec 31 | Size of Issuer (Assets): | $25,000,001 to $100,000,000 |
|
